In what can be a watershed in cancer research, Scottish scientists along with US Biotech Company Viragen Inc., have used nuclear transfer technology
In what can be a watershed in cancer research, Scottish scientists along with US Biotech Company Viragen Inc., have used nuclear transfer technology to harvest life saving drugs to treat many serious diseases including cancer.
The same team had earlier cornered world wide fame and glory (and a lot of criticism!) for creating Dolly – the world’s first cloned mammal: Using the same nuclear transfer technology it is possible, according to these scientists to create human therapeutic proteins in chicken eggs – which can be used as drugs to treat serious diseases. Professor Grahame Bulfield, Director of Roslin Institute at Edinburgh, said, “ The collaboration with Viragen is a key part of our strategy to expand the institute’s development of medical applications of Dolly technology”.
